Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

TXG.US Logo

TXG.US - Current Price

$20.52

Company Information

Company Name
10X Genomics Inc
Sector
Healthcare
Industry
Health Information Services
Exchange
NASDAQ
ISIN: US88025U1097
CIK: 0001770787
CUSIP: 88025U109
Currency: USD
Full Time Employees: 1,306
Phone: 925 401 7300
Fiscal Year End: December
IPO Date: Sep 12, 2019
Description:

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Address:

6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Directors & Officers

Name Title Year Born
Dr. Serge Saxonov Ph.D. Co-Founder, CEO & Director 1977
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer & Director 1975
Mr. Adam S. Taich CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer 1975
Mr. Jim Goodrich Chief of Global Operations NA
Mr. Michael Schnall-Levin Ph.D. Founding Scientist & CTO NA
Ms. Cassie Corneau Manager of Investor Relations & Strategic Finance NA
Dr. Randy Wu General Counsel and Secretary NA
Ms. Mennah Moustafa Chief Commercial Officer NA
Mr. Jens Durruthy Associate Director of Product Management NA

Shares Statistics

Shares Outstanding: 116.47M
Shares Float: 114.31M
% Insiders: 182.40%
% Institutions: 10,857.60%
Short % Float: 19.03%

Valuation Metrics

Enterprise Value: $2.20B
Trailing P/E: 0.00
Forward P/E: 196.08

Financial Highlights

Market Cap: $2.60B
EBITDA: $-97.50M
Book Value: $6.21
Earnings/Share: $-0.63
Profit Margin: -11.89%
Operating Margin: -21.17%
ROA (TTM): -8.42%
ROE (TTM): -10.12%
Revenue (TTM): $641.81M
Revenue/Share (TTM): $5.20
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -1.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.22 N/A 10,000.00%
Sep 30, 2025 -0.02 -0.07 N/A 6,742.86%
Jun 30, 2025 0.28 -0.31 N/A 19,032.26%
Mar 31, 2025 -0.28 -0.47 N/A 4,042.55%
Dec 31, 2024 -0.14 -0.11 N/A -2,727.27%
Sep 30, 2024 -0.02 -0.26 N/A 9,230.77%
Jun 30, 2024 -0.32 -0.48 N/A 3,333.33%
Mar 31, 2024 -0.50 -0.50 N/A 0.00%
Dec 31, 2023 -0.41 -0.36 N/A -1,388.89%
Sep 30, 2023 -0.79 -0.46 N/A -7,173.91%
Jun 30, 2023 -0.53 -0.40 N/A -3,250.00%
Mar 31, 2023 -0.44 -0.37 N/A -1,891.89%
Dec 31, 2022 -0.15 -0.31 N/A 5,161.29%
Sep 30, 2022 -0.37 -0.46 N/A 1,956.52%
Jun 30, 2022 -0.57 -0.39 N/A -4,615.38%
Mar 31, 2022 -0.38 -0.31 N/A -2,258.06%
Dec 31, 2021 -0.16 -0.09 N/A -7,777.78%
Sep 30, 2021 -0.15 -0.20 N/A 2,500.00%
Jun 30, 2021 -0.10 -0.26 N/A 6,153.85%
Mar 31, 2021 -0.11 -0.27 N/A 5,925.93%
Dec 31, 2020 -3.87 -0.23 N/A -158,260.87%
Sep 30, 2020 -0.65 -0.31 N/A -10,967.74%
Jun 30, 2020 -0.41 -0.55 N/A 2,545.45%
Mar 31, 2020 -0.20 -0.13 N/A -5,384.62%
Dec 31, 2019 -0.07 -0.11 N/A 3,636.36%
Sep 30, 2019 -0.33 -0.12 N/A -17,500.00%
Jun 30, 2019 -0.16 -0.11 N/A -4,545.45%

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $344.07M $N/A $918.64M $208.50M $710.13M
2023-12-31 $359.28M $N/A $965.14M $224.10M $741.04M
2022-12-31 $219.75M $N/A $1.03B $223.24M $805.74M
2021-12-31 $587.45M $N/A $1.02B $201.26M $817.57M
2020-12-31 $663.60M $N/A $929.34M $190.27M $739.07M
2019-12-31 $424.17M $N/A $605.92M $185.84M $420.08M
2018-12-31 $65.08M $N/A $124.31M $344.30M $-219.99M
2017-12-31 $47.86M $N/A $75.61M $188.12M $-112.51M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 22, 2025 N/A N/A N/A N/A N/A N/A
Aug 22, 2025 N/A N/A N/A N/A N/A N/A
Aug 22, 2025 N/A N/A N/A N/A N/A N/A
May 22, 2025 N/A N/A N/A N/A N/A N/A
May 22, 2025 N/A N/A N/A N/A N/A N/A
May 22, 2025 N/A N/A N/A N/A N/A N/A
Feb 24, 2025 N/A N/A N/A N/A N/A N/A
Feb 24, 2025 N/A N/A N/A N/A N/A N/A
Feb 21, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist